Literature DB >> 8241291

A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver.

J D Bell1, I J Cox, J Sargentoni, C J Peden, D K Menon, C S Foster, P Watanapa, R A Iles, J Urenjak.   

Abstract

Spectral changes in human hepatic tumours and possible systemic effects of tumour on host liver were assessed by 31P and 1H in vitro NMR spectroscopy. The 1H and 31P spectra from liver tumour biopsies showed significant elevation in phosphoethanolamine, phosphocholine, taurine, citrate, alanine, lactate and glycine, and significant reduction in GPE (glycerophosphoethanolamine), GPC (glycerophosphocholine), creatine and threonine compared to histologically normal tissue. 31P-NMR spectra obtained from histologically normal tissue within tumour-bearing livers showed significant elevation in phosphoethanolamine and phosphocholine compared to data from liver biopsies from nontumour-bearing patients (pancreatitis). These results suggest that alterations in membrane metabolism in host liver can be detected by 31P-NMR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8241291     DOI: 10.1016/0925-4439(93)90124-j

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

Review 1.  [(1)H magnetic resonance spectroscopy (MRS) of the liver and hepatic malignant tumors at 3.0 Tesla].

Authors:  F Fischbach; M Thormann; J Ricke
Journal:  Radiologe       Date:  2004-12       Impact factor: 0.635

Review 2.  Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer.

Authors:  Pieter C Dagnelie; Susanne Leij-Halfwerk
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

Review 3.  Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma.

Authors:  Tiffany Hennedige; Sudhakar K Venkatesh
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Metabolic profiling of the rat liver after chronic ingestion of alpha-naphthylisothiocyanate using in vivo and ex vivo magnetic resonance spectroscopy.

Authors:  Bhavana S Solanky; Gina J Sanchez-Canon; Jeremy F L Cobbold; Simon D Taylor-Robinson; Jimmy D Bell; Cheryl L Scudamore; Eleanor Ross; Julie C Holder; Po-Wah So; I Jane Cox
Journal:  Toxicol Sci       Date:  2012-01-18       Impact factor: 4.849

5.  Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease.

Authors:  I Jane Cox; Amar Sharif; Jeremy F L Cobbold; Howard C Thomas; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

Review 6.  In vivo magnetic resonance spectroscopy of liver tumors and metastases.

Authors:  E G W ter Voert; L Heijmen; H W M van Laarhoven; A Heerschap
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

7.  Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models.

Authors:  R Jalan; J Sargentoni; G A Coutts; J D Bell; K Rolles; A K Burroughs; S D Taylor Robinson
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

8.  ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy.

Authors:  R Müllenbach; A Bennett; N Tetlow; N Patel; G Hamilton; F Cheng; J Chambers; R Howard; S D Taylor-Robinson; C Williamson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

9.  In vivo, high-field, 3-Tesla 1H MR spectroscopic assessment of liver fibrosis in HCV-correlated chronic liver disease.

Authors:  A Orlacchio; F Bolacchi; M Angelico; A Mancini; V Cozzolino; M Cadioli; G Simonetti
Journal:  Radiol Med       Date:  2008-04-02       Impact factor: 3.469

10.  Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease.

Authors:  Bengt Norén; Peter Lundberg; Marcus Ressner; Staffan Wirell; Sven Almer; Orjan Smedby
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.